{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T04:43:32Z","timestamp":1771994612671,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.4158\/ep-2019-0244","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T13:36:25Z","timestamp":1566999385000},"page":"36-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Thyroid Dysfunction, Recovery, and Prognosis in Melanoma Patients Treated with Immune Checkpoint Inhibitors: A Retrospective Review"],"prefix":"10.1016","volume":"26","author":[{"given":"Mazen","family":"Al Mushref","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Guido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances A.","family":"Collichio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic T.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Clemmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0244_bb0010","first-page":"133","volume":"191","author":"Wilson","year":"2018","journal-title":"Immune checkpoint inhibitors: new strategies to checkmate cancer"},{"key":"10.4158\/EP-2019-0244_bb0015","first-page":"139","volume":"54","author":"Michot","year":"2016","journal-title":"Immune-related adverse events with immune checkpoint blockade: a comprehensive review"},{"key":"10.4158\/EP-2019-0244_bb0020","first-page":"1714","volume":"36","author":"Brahmer","year":"2018","journal-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline"},{"key":"10.4158\/EP-2019-0244_bb0025","first-page":"70","volume":"58","author":"Sznol","year":"2017","journal-title":"Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management"},{"key":"10.4158\/EP-2019-0244_bb0030","first-page":"1","volume":"5","author":"Tan","year":"2019","journal-title":"Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports"},{"key":"10.4158\/EP-2019-0244_bb0035","first-page":"4078","volume":"99","author":"Faje","year":"2014","journal-title":"Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma"},{"key":"10.4158\/EP-2019-0244_bb0040","first-page":"583","volume":"28","author":"Osorio","year":"2017","journal-title":"Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer"},{"key":"10.4158\/EP-2019-0244_bb0045","first-page":"749","volume":"21","author":"Min","year":"2015","journal-title":"Systemic high dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study"},{"key":"10.4158\/EP-2019-0244_bb0050","first-page":"4431","volume":"101","author":"de Filette","year":"2016","journal-title":"Incidence of thyroid-related adverse events in melanoma patients treated with pembrolizumab"},{"key":"10.4158\/EP-2019-0244_bb0055","first-page":"173","volume":"4","author":"Barroso-Sousa","year":"2017","journal-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20350734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20350734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:08:51Z","timestamp":1761516531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20350734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1530891X20350734"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0244","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid Dysfunction, Recovery, and Prognosis in Melanoma Patients Treated with Immune Checkpoint Inhibitors: A Retrospective Review","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}